Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension [Phase 2]
A Phase 2 8-week trial evaluated the dose response of AHU377 in combination with valsartan in patients with mild-to-moderate systolic hypert…
-
CLINICAL_TRIALS withdrawal · 2015-08-18Clinical Trial Update: Rapid Renal Sympathetic Denervation for Resistant Hypertension II [Phase 2, Phase 3]
Medtronic Endovascular's rapid renal sympathetic denervation trial for resistant hypertension (Phase 2/3) has been withdrawn. The trial was …
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation [Phase 4]
Phase 4 trial evaluating the pharmacology of combining aliskiren with cyclosporine in cardiac transplant patients, focusing on hypertension …
-
FDA approval · 2015-08-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approves Northstar RxLLC's supplemental application for enalapril maleate, confirming the approval of this generic ACE inhibitor.
-
FDA approval · 2015-08-17FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for enalapril maleate filed by Northstar RxLLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-08-17Clinical Trial Update: The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults [NA]
This clinical trial update describes a completed study comparing pork versus chicken/fish within a DASH diet and its effects on blood pressu…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction [Phase 3]
Phase 3 trial evaluating safety, tolerability and efficacy of LCZ696 (sacubitril/valsartan) in Japanese hypertensive patients with renal dys…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: The Effect of Phentermine and B12 on Weight Loss Among Obese Patients [EARLY_Phase 1]
An early Phase 1 trial evaluated whether combining Phentermine with Vitamin B12 promotes weight loss in obese patients; the study has comple…
-
FDA approval · 2015-08-13FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for metoprolol tartrate from Fresenius Kabi USA, LLC.
-
FDA approval · 2015-08-12FDA Approved: LOSARTAN POTASSIUM — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original generic application for losartan potassium, a generic version of the hypertension medication l…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects [Phase 2]
Phase 2 study evaluating the metabolic effects of LCZ696 (sacubitril/valsartan) compared with amlodipine in obese hypertensive subjects; res…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Efficacy and Safety of LCZ696A in Patients With Essential Hypertension [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of LCZ696A (sacubitril/valsartan) for essential hypertension, reporting effects on blood p…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients
This clinical trial update evaluates whether Ramadan fasting affects achieving JNC-7 blood pressure goals in hypertensive patients at cardio…
-
FDA approval · 2015-08-07FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2015-08-05Clinical Trial Update: Equol Supplementation on Blood Pressure and Vascular Function [NA]
A clinical trial conducted by the Chinese University of Hong Kong is investigating whether equol supplementation improves blood pressure and…
-
CLINICAL_TRIALS research · 2015-08-04Clinical Trial Update: e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions [NA]
This clinical trial update discusses the e-Pharmacovigilance II program focused on safety and effectiveness monitoring and calls for earlier…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: EVALUATION OF THE RELATIONSHIP BETWEEN EFFERVESCENT PARACETAMOL AND BLOOD PRESSURE. CLINICAL TRIAL. [Phase 4]
A Phase 4 clinical trial is evaluating the relationship between effervescent paracetamol and blood pressure. The study status is currently u…
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation [Phase 2]
Phase 2 trial evaluating the standardization of ginseng and its components for blood pressure regulation has completed.
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population
The study evaluates whether blood pressure and arterial stiffness predict health outcomes in institutionalized very elderly individuals. The…
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Burdock and Blood Pressure in African-American Women [NA]
This update describes a clinical trial investigating the effect of burdock on blood pressure in African-American women with hypertension.
-
CLINICAL_TRIALS research · 2015-07-29Clinical Trial Update: A Team-Based Care for Hypertension Management (TBC-HTA) [NA]
Update on the NCT02511093 trial evaluating team-based care for hypertension management, sponsored by Centre Hospitalier Universitaire Vaudoi…
-
FDA approval · 2015-07-29FDA Approved: NEBIVOLOL — Original Application (Ascend Laboratories, LLC)
The FDA approved the original generic application for Nebivolol by Ascend Laboratories, LLC.
-
FDA approval · 2015-07-28FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT (amlodipine/valsartan/hydrochlorothiazide) from Novartis Pharmaceuticals Corporation…
-
FDA approval · 2015-07-28FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE (amlodipine besilate and valsartan) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia [Phase 2, Phase 3]
This clinical trial update discusses a Phase 2/Phase 3 study of nonsteroidal antiinflammatory drugs for postpartum preeclampsia in women. Th…